- Report
- February 2020
- 250 Pages
France
From €2383EUR$2,500USD£2,031GBP
- Report
- July 2019
- 250 Pages
France
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 250 Pages
United States
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 251 Pages
United Kingdom
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 250 Pages
Spain
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 250 Pages
Japan
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 250 Pages
Italy
From €2193EUR$2,300USD£1,869GBP
- Report
- July 2019
- 250 Pages
Germany
From €2193EUR$2,300USD£1,869GBP
From €1764EUR$1,850USD£1,503GBP
- Report
- December 2021
- 159 Pages
Global
From €3539EUR$3,712USD£3,016GBP
- Report
- December 2023
- 221 Pages
Global
From €2668EUR$2,799USD£2,274GBP
- Book
- August 2019
North America
The HIV Test market is a subset of the larger Infectious Disease Testing market. HIV testing is used to detect the presence of the Human Immunodeficiency Virus (HIV) in a person's blood, saliva, or urine. HIV testing is used to diagnose HIV infection, monitor the progression of the virus, and assess the effectiveness of treatments. HIV testing is also used to identify individuals who may be at risk of HIV infection and to prevent the spread of the virus.
The HIV Test market is highly competitive, with a variety of companies offering different types of tests. Companies such as Abbott, Bio-Rad, Roche, and Siemens offer rapid HIV tests, which provide results in a matter of minutes. Other companies, such as Cepheid, Hologic, and Quidel, offer molecular HIV tests, which provide more accurate results. Additionally, companies such as Alere, Becton Dickinson, and Ortho Clinical Diagnostics offer enzyme immunoassay (EIA) tests, which are used to detect antibodies to HIV. Show Less Read more